Tootsie Roll Industries, Inc. (TR) Income Statement Analysis

See more : PT Golden Plantation Tbk (GOLL.JK) Income Statement Analysis – Financial Results

Complete financial analysis of Tootsie Roll Industries, Inc. (TR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tootsie Roll Industries, Inc., a leading company in the Food Confectioners industry within the Consumer Defensive sector.

You may be interested

Korea Cast Iron Pipe Ind. Co., Ltd. (000970.KS) Income Statement Analysis – Financial Results
Finolex Cables Limited (FINCABLES.NS) Income Statement Analysis – Financial Results
PT Red Planet Indonesia Tbk (PSKT.JK) Income Statement Analysis – Financial Results
AirBoss of America Corp. (BOS.TO) Income Statement Analysis – Financial Results
OmniAb, Inc. (OABIW) Income Statement Analysis – Financial Results

Tootsie Roll Industries, Inc. (TR)

Industry: Food Confectioners

Sector: Consumer Defensive

Website: https://www.tootsie.com

About Tootsie Roll Industries, Inc.

Tootsie Roll Industries, Inc., together with its subsidiaries, engages in manufacture and sale of confectionery products in the United States, Canada, Mexico, and internationally. It sells its products under the Tootsie Roll, Tootsie Pops, Child's Play, Caramel Apple Pops, Charms, Blow-Pop, Charms Mini Pops, Cella's, Dots, Junior Mints, Charleston Chew, Sugar Daddy, Sugar Babies, Andes, Fluffy Stuff, Dubble Bubble, Razzles, Cry Baby, NIK-L-NIP, and Tutsi Pop trademarks. The company sells its products directly to wholesale distributors of candy, food and groceries, supermarkets, variety stores, dollar stores, chain grocers, drug chains, discount chains, cooperative grocery associations, mass merchandisers, warehouse and membership club stores, vending machine operators, e-commerce merchants, the United States military, and fund-raising charitable organizations, as well as through food and grocery brokers. Tootsie Roll Industries, Inc. was founded in 1896 and is based in Chicago, Illinois.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue	769.37M	681.44M	566.04M	471.06M	523.62M	518.92M	519.29M	521.10M	540.11M	543.53M	543.38M	549.87M	532.51M	521.45M	499.33M	496.02M	497.72M	495.99M	487.74M	420.11M	392.66M	393.19M	423.50M	427.05M	396.80M	388.70M	375.60M	340.90M	312.70M	296.90M	259.60M	245.40M	207.90M	194.30M	179.30M	128.60M	114.80M	111.40M	106.70M
Cost of Revenue	512.53M	454.24M	371.54M	300.70M	330.10M	330.75M	326.90M	321.31M	340.98M	341.88M	351.90M	366.55M	366.26M	349.40M	319.50M	334.24M	329.04M	310.51M	299.16M	244.50M	222.55M	220.77M	216.66M	197.21M	185.30M	177.50M	178.20M	169.20M	156.00M	145.10M	125.20M	121.10M	102.10M	97.50M	88.90M	101.20M	54.70M	53.70M	53.90M
Gross Profit	256.84M	227.20M	194.51M	170.36M	193.52M	188.17M	192.39M	199.79M	199.13M	201.65M	191.49M	183.32M	166.24M	172.05M	179.83M	161.78M	168.67M	185.48M	188.58M	175.61M	170.11M	172.42M	206.84M	229.85M	211.50M	211.20M	197.40M	171.70M	156.70M	151.80M	134.40M	124.30M	105.80M	96.80M	90.40M	27.40M	60.10M	57.70M	52.80M
Gross Profit Ratio	33.38%	33.34%	34.36%	36.17%	36.96%	36.26%	37.05%	38.34%	36.87%	37.10%	35.24%	33.34%	31.22%	32.99%	36.01%	32.62%	33.89%	37.40%	38.66%	41.80%	43.32%	43.85%	48.84%	53.82%	53.30%	54.33%	52.56%	50.37%	50.11%	51.13%	51.77%	50.65%	50.89%	49.82%	50.42%	21.31%	52.35%	51.80%	49.48%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	89.55M	54.63M	76.82M	69.52M	78.51M	68.16M	76.90M	66.62M	65.43M	71.20M	73.77M	68.77M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	65.47M	67.34M	55.29M	42.59M	49.29M	49.53M	44.08M	40.76M	42.62M	46.53M	45.37M	45.07M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	155.01M	121.98M	132.11M	112.12M	127.80M	117.69M	120.98M	107.38M	108.05M	117.72M	119.13M	113.84M	108.28M	106.32M	103.76M	95.25M	97.82M	99.23M	96.94M	85.71M	77.76M	75.75M	109.12M	105.81M	97.00M	97.10M	94.50M	88.10M	84.50M	78.70M	70.60M	69.10M	58.10M	54.30M	51.40M	0.00	33.20M	31.40M	29.20M
Other Expenses	0.00	805.00K	1.03M	1.12M	1.23M	1.13M	202.00K	153.00K	128.00K	27.00K	2.92M	264.00K	0.00	0.00	0.00	0.00	0.00	0.00	-17.10M	0.00	0.00	87.00M	3.78M	13.31M	10.00M	12.80M	12.80M	12.10M	10.70M	10.50M	8.80M	6.10M	5.20M	5.70M	5.10M	3.60M	2.40M	2.10M	2.40M
Operating Expenses	155.01M	121.98M	132.11M	112.12M	127.80M	117.69M	120.98M	107.38M	108.05M	117.72M	119.13M	113.84M	108.28M	106.32M	103.76M	95.25M	97.82M	99.23M	79.84M	85.71M	77.76M	162.75M	112.90M	119.12M	107.00M	109.90M	107.30M	100.20M	95.20M	89.20M	79.40M	75.20M	63.30M	60.00M	56.50M	3.60M	35.60M	33.50M	31.60M
Cost & Expenses	667.54M	576.22M	503.64M	412.82M	457.90M	448.44M	447.87M	428.69M	449.03M	459.60M	471.03M	480.39M	474.54M	455.72M	423.25M	429.49M	426.87M	409.74M	379.00M	330.21M	300.30M	383.52M	329.55M	316.33M	292.30M	287.40M	285.50M	269.40M	251.20M	234.30M	204.60M	196.30M	165.40M	157.50M	145.40M	104.80M	90.30M	87.20M	85.50M
Interest Income	5.21M	2.64M	2.74M	4.01M	4.42M	3.54M	2.85M	2.13M	1.42M	1.58M	1.45M	1.37M	1.09M	879.00K	1.44M	3.45M	3.50M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	337.00K	104.00K	46.00K	164.00K	220.00K	181.00K	144.00K	105.00K	76.00K	99.00K	92.00K	137.00K	121.00K	142.00K	243.00K	378.00K	535.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	18.24M	17.67M	17.57M	18.18M	18.78M	18.67M	18.99M	19.63M	20.39M	20.76M	20.05M	19.93M	19.23M	18.28M	17.86M	17.04M	16.38M	16.73M	16.37M	13.57M	11.38M	12.35M	16.70M	13.31M	10.00M	12.80M	12.80M	12.10M	10.70M	10.50M	8.80M	6.10M	5.20M	5.70M	5.10M	3.60M	2.40M	2.10M	2.40M
EBITDA	138.47M	112.88M	84.70M	76.43M	99.25M	89.21M	91.78M	110.86M	112.42M	108.44M	100.53M	94.23M	80.26M	92.51M	82.28M	73.32M	93.38M	104.25M	125.11M	103.47M	103.73M	22.02M	110.64M	124.04M	114.50M	114.10M	102.90M	83.60M	72.20M	73.10M	63.80M	55.20M	47.70M	42.50M	39.00M	27.40M	26.90M	26.30M	23.60M
EBITDA Ratio	18.00%	19.35%	15.63%	17.31%	17.88%	18.08%	18.00%	21.94%	20.93%	19.56%	17.63%	16.37%	14.66%	16.21%	19.10%	17.54%	17.25%	19.44%	21.14%	23.49%	24.99%	4.58%	24.51%	27.39%	27.12%	28.12%	25.99%	23.47%	22.26%	25.13%	23.54%	21.39%	22.13%	21.67%	22.14%	19.52%	22.13%	22.26%	20.90%
Operating Income	101.83M	110.76M	67.13M	58.24M	69.21M	70.48M	71.42M	92.41M	91.08M	83.92M	72.35M	69.48M	57.97M	65.73M	62.08M	66.53M	70.85M	86.25M	108.74M	89.90M	92.35M	9.67M	93.94M	110.73M	104.50M	101.30M	90.10M	71.50M	61.50M	62.60M	55.00M	49.10M	42.50M	36.80M	33.90M	23.80M	24.50M	24.20M	21.20M
Operating Income Ratio	13.24%	16.25%	11.86%	12.36%	13.22%	13.58%	13.75%	17.73%	16.86%	15.44%	13.32%	12.64%	10.89%	12.61%	12.43%	13.41%	14.24%	17.39%	22.30%	21.40%	23.52%	2.46%	22.18%	25.93%	26.34%	26.06%	23.99%	20.97%	19.67%	21.08%	21.19%	20.01%	20.44%	18.94%	18.91%	18.51%	21.34%	21.72%	19.87%
Total Other Income/Expenses	18.07M	-12.61M	18.60M	18.02M	16.19M	2.72M	14.14M	6.68M	1.50M	7.37M	12.13M	4.69M	2.95M	8.36M	2.10M	-10.62M	6.13M	8.47M	22.01M	4.55M	5.59M	91.02M	6.84M	7.08M	6.90M	4.70M	5.30M	3.60M	2.60M	-1.40M	2.70M	2.80M	1.60M	400.00K	-700.00K	1.70M	1.50M	1.50M	1.40M
Income Before Tax	119.89M	98.14M	85.73M	76.26M	85.40M	73.21M	84.56M	97.91M	92.58M	91.29M	84.48M	74.16M	60.91M	74.09M	64.18M	55.91M	77.17M	94.72M	113.65M	94.69M	97.95M	100.69M	100.79M	117.81M	111.40M	106.00M	95.40M	75.10M	64.10M	61.20M	57.70M	51.90M	44.10M	37.20M	33.20M	25.50M	26.00M	25.70M	22.60M
Income Before Tax Ratio	15.58%	14.40%	15.15%	16.19%	16.31%	14.11%	16.28%	18.79%	17.14%	16.80%	15.55%	13.49%	11.44%	14.21%	12.85%	11.27%	15.50%	19.10%	23.30%	22.54%	24.94%	25.61%	23.80%	27.59%	28.07%	27.27%	25.40%	22.03%	20.50%	20.61%	22.23%	21.15%	21.21%	19.15%	18.52%	19.83%	22.65%	23.07%	21.18%
Income Tax Expense	28.01M	22.25M	20.42M	17.29M	20.57M	16.40M	3.91M	30.59M	26.45M	28.43M	23.63M	22.16M	16.97M	20.38M	10.70M	17.13M	25.54M	28.80M	36.43M	30.51M	32.93M	34.30M	35.10M	42.07M	40.10M	38.50M	34.70M	27.90M	23.70M	23.30M	22.30M	19.90M	17.60M	14.60M	13.00M	8.90M	11.40M	12.90M	11.70M
Net Income	91.91M	75.94M	65.33M	59.00M	64.92M	56.89M	80.86M	67.51M	66.09M	63.30M	60.85M	52.00M	43.94M	53.71M	53.48M	38.78M	51.63M	65.92M	77.23M	64.17M	65.01M	66.39M	65.69M	75.74M	71.30M	67.50M	60.70M	47.20M	40.40M	37.90M	35.40M	32.00M	26.50M	22.60M	20.20M	16.60M	14.60M	12.80M	10.90M
Net Income Ratio	11.95%	11.14%	11.54%	12.52%	12.40%	10.96%	15.57%	12.96%	12.24%	11.65%	11.20%	9.46%	8.25%	10.30%	10.71%	7.82%	10.37%	13.29%	15.83%	15.28%	16.56%	16.88%	15.51%	17.73%	17.97%	17.37%	16.16%	13.85%	12.92%	12.77%	13.64%	13.04%	12.75%	11.63%	11.27%	12.91%	12.72%	11.49%	10.22%
EPS	1.28	1.04	0.89	0.79	0.86	0.76	1.08	0.88	0.85	0.80	0.76	0.64	0.54	0.64	0.63	0.45	0.58	0.74	0.85	0.70	0.70	0.69	0.68	0.78	0.74	0.67	0.58	0.46	0.40	0.37	0.36	0.31	0.27	0.03	0.22	0.17	0.15	0.12	0.11
EPS Diluted	1.28	1.04	0.89	0.79	0.86	0.76	1.08	0.88	0.85	0.80	0.76	0.64	0.54	0.64	0.63	0.45	0.58	0.74	0.85	0.70	0.70	0.69	0.68	0.78	0.74	0.67	0.58	0.46	0.40	0.37	0.36	0.31	0.27	0.03	0.22	0.17	0.15	0.12	0.11
Weighted Avg Shares Out	71.92M	73.02M	73.68M	74.86M	75.90M	74.38M	75.37M	76.46M	77.74M	78.92M	80.05M	81.22M	82.45M	83.60M	84.79M	85.91M	88.16M	89.54M	91.04M	91.80M	93.53M	95.90M	96.26M	96.94M	96.43M	100.61M	104.59M	102.20M	102.24M	102.26M	98.22M	102.10M	97.56M	94.71M	92.07M	96.30M	59.87M	106.54M	99.36M
Weighted Avg Shares Out (Dil)	71.92M	73.02M	73.68M	74.86M	75.90M	74.38M	75.37M	76.46M	77.74M	78.92M	80.05M	81.22M	82.45M	83.60M	84.79M	86.17M	88.16M	90.37M	91.41M	92.14M	94.26M	96.20M	96.26M	100.96M	96.43M	100.61M	104.59M	102.20M	105.29M	103.24M	98.22M	102.10M	97.56M	94.71M	92.07M	96.30M	59.87M	106.54M	99.36M

3 Dividend Kings with a Royally Good Upside

August 22, 2023marketbeat.com

Dividend Kings are tried and true investments with a long history of sustained dividend payments and distribution increases. The kind of track records that help investors sleep soundly at night, but these stocks are not always easy to buy.

Tootsie Roll sees ‘significantly higher' ingredient costs into 2024

July 25, 2023marketwatch.com

Tootsie Roll Industries TR, -0.24% experienced higher ingredient costs in 2023, and expects more of the same for 2024.

Score These 3 Oversold Dividend Kings Now for Majestic Long-Term Profits

July 7, 2023investorplace.com

Struggling to find stocks to improve your portfolio's total return? In today's market, finding stocks that balance risk and return is the struggle of most investors.

The 7 Most Undervalued Consumer Stocks to Buy Now

June 29, 2023investorplace.com

Recession, interest rates, employment, and the housing market – American consumers are weighing the futures of all these topics. Apprehension has led to a fallback in spending.

Tootsie Roll Industries: Don't Expect Rocket-Like Growth, Hold It For The Dividend

June 29, 2023seekingalpha.com

Tootsie Roll Industries is a slow-growth company with a high earnings multiple, but it offers a regular cash and stock dividend. Despite operating in a mature industry with larger competitors, Tootsie Roll has a competitive advantage due to the brand...

Don't Get Trapped in These 3 Overvalued Blue-Chips

June 19, 2023investorplace.com

Investors have long favored growth and income stocks which deliver reliable dividends and modest capital appreciation over time. But these high P/E blue chips carry risk if the price isn't right.

Tootsie Roll Industries: Still Expensive Despite Great Performance

May 23, 2023seekingalpha.com

Tootsie Roll Industries has seen a significant upside in recent months due to favorable financial results. The company's shares appear to be lofty, so investors should tread cautiously moving forward.

Check Out These Sweet Defensive Stocks Hitting New Highs

March 27, 2023investors.com

Defensive stocks in focus: chocolate and confectionary stocks are hitting new highs. Some are in bases while others are in buy zones.

New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023headlinesoftoday.com

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR) Findings...